Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mittal

Showing results (721-730 of 722) with videos related to

Pageof 73
Sort By:
You have reached the last page of results.This site can display upto 722 results.
Science (New York, N.Y.)|April 25, 2020
Determination of the melanocortin-4 receptor structure identifies Ca<sup>2+</sup> as a cofactor for ligand bindingJing Yu, Luis E Gimenez, Ciria C Hernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2021
High-Specific-Activity-<sup>131</sup>I-MIBG versus <sup>177</sup>Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and ParagangliomaAbhishek Jha, David Taïeb, Jorge A Carrasquillo, et al.
Pageof 73

Showing results (721-730 of 722) with videos related to

Sort By:
Pageof 73
You have reached the last page of results.This site can display upto 722 results.
Science (New York, N.Y.)|April 25, 2020
Determination of the melanocortin-4 receptor structure identifies Ca<sup>2+</sup> as a cofactor for ligand bindingJing Yu, Luis E Gimenez, Ciria C Hernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2021
High-Specific-Activity-<sup>131</sup>I-MIBG versus <sup>177</sup>Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and ParagangliomaAbhishek Jha, David Taïeb, Jorge A Carrasquillo, et al.
Pageof 73